<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/rphm" ></link>
<id>urn:uuid:8b0219ee-4f84-c8e3-3519-375760c726e9</id>
<updated>2026-07-31T14:09:47-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>RPHM: SACCOMANO NICHOLAS A (PR,CEO,DIR) Sold (JS*) 86 Shares of ONKURE THERAPEUTICS INC for $4.40 on 6/22</title>
<link href="http://www.insiderinsights.com/company/rphm/onkure-therapeutics-inc/id-6432126" ></link>
<id>urn:uuid:22a3703b-2cff-b14c-2aad-725a36fdb394</id>
<updated>2026-06-24T19:29:18-04:00</updated>
<summary type="html" ><![CDATA[ONKURE THERAPEUTICS INC (RPHM)]]></summary>
</entry>
<entry>
<title>RPHM: LEVERONE JASON A (CFO) Sold (JS*) 303 Shares of ONKURE THERAPEUTICS INC for $4.40 on 6/22</title>
<link href="http://www.insiderinsights.com/company/rphm/onkure-therapeutics-inc/id-6432113" ></link>
<id>urn:uuid:a3d162ba-3001-edb2-55a2-fb2152f96270</id>
<updated>2026-06-24T19:27:44-04:00</updated>
<summary type="html" ><![CDATA[ONKURE THERAPEUTICS INC (RPHM)]]></summary>
</entry>
<entry>
<title>RPHM: AI BIOTECHNOLOGY LLC (BO) Filed a Form 3, Becoming a Registered Insider at ONKURE THERAPEUTICS INC With Initial Direct Holdings of 4.0mm</title>
<link href="http://www.insiderinsights.com/company/rphm/onkure-therapeutics-inc/id-6383387" ></link>
<id>urn:uuid:e95d0c07-efc0-04a9-b768-4823af491a68</id>
<updated>2026-04-07T21:15:00-04:00</updated>
<summary type="html" ><![CDATA[ONKURE THERAPEUTICS INC (RPHM)]]></summary>
</entry>
<entry>
<title>RPHM: RATCLIFFE LIAM (DIR) Filed a Form 3, Becoming a Registered Insider at ONKURE THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/rphm/onkure-therapeutics-inc/id-6377861" ></link>
<id>urn:uuid:c67650f9-57c6-1986-900a-a29dc6eaec37</id>
<updated>2026-04-01T17:24:12-04:00</updated>
<summary type="html" ><![CDATA[ONKURE THERAPEUTICS INC (RPHM)]]></summary>
</entry>
<entry>
<title>RPHM: SACCOMANO NICHOLAS A (PR,CEO,DIR) Sold (JS*) 86 Shares of ONKURE THERAPEUTICS INC for $4.16 on 3/23</title>
<link href="http://www.insiderinsights.com/company/rphm/onkure-therapeutics-inc/id-6372980" ></link>
<id>urn:uuid:8f099b76-da12-b2dc-9ab3-63fb51d01c69</id>
<updated>2026-03-24T18:57:58-04:00</updated>
<summary type="html" ><![CDATA[ONKURE THERAPEUTICS INC (RPHM)]]></summary>
</entry>
<entry>
<title>RPHM: LEVERONE JASON A (CFO) Sold (JS*) 301 Shares of ONKURE THERAPEUTICS INC for $4.16 on 3/23</title>
<link href="http://www.insiderinsights.com/company/rphm/onkure-therapeutics-inc/id-6372979" ></link>
<id>urn:uuid:beb36d93-05cb-4768-e866-6f74fe405149</id>
<updated>2026-03-24T18:56:09-04:00</updated>
<summary type="html" ><![CDATA[ONKURE THERAPEUTICS INC (RPHM)]]></summary>
</entry>
<entry>
<title>RPHM: MATHERS EDWARD T (DIR) Acquired (JB) 3,911 Shares of ONKURE THERAPEUTICS INC for $0.00 on 12/31</title>
<link href="http://www.insiderinsights.com/company/rphm/onkure-therapeutics-inc/id-6299483" ></link>
<id>urn:uuid:9c47f199-6496-6da7-1a4d-82ef1fe2c75b</id>
<updated>2026-01-02T16:16:56-05:00</updated>
<summary type="html" ><![CDATA[ONKURE THERAPEUTICS INC (RPHM)]]></summary>
</entry>
<entry>
<title>RPHM: MANKE ISAAC (DIR) Acquired (JB) 5,258 Shares of ONKURE THERAPEUTICS INC for $0.00 on 12/31</title>
<link href="http://www.insiderinsights.com/company/rphm/onkure-therapeutics-inc/id-6299428" ></link>
<id>urn:uuid:3eaa5335-0a48-1180-69e7-f09a1f6b9497</id>
<updated>2026-01-02T16:10:23-05:00</updated>
<summary type="html" ><![CDATA[ONKURE THERAPEUTICS INC (RPHM)]]></summary>
</entry>
<entry>
<title>RPHM: SACCOMANO NICHOLAS A (PR,CEO,DIR) Sold (JS*) 87 Shares of ONKURE THERAPEUTICS INC for $2.97 on 12/22</title>
<link href="http://www.insiderinsights.com/company/rphm/onkure-therapeutics-inc/id-6297637" ></link>
<id>urn:uuid:0d7b2908-9ffb-4447-0a22-8c0c77040812</id>
<updated>2025-12-23T20:09:47-05:00</updated>
<summary type="html" ><![CDATA[ONKURE THERAPEUTICS INC (RPHM)]]></summary>
</entry>
<entry>
<title>RPHM: LEVERONE JASON A (CFO) Sold (JS*) 302 Shares of ONKURE THERAPEUTICS INC for $2.97 on 12/22</title>
<link href="http://www.insiderinsights.com/company/rphm/onkure-therapeutics-inc/id-6297634" ></link>
<id>urn:uuid:176fbfaa-57c9-3a63-5b68-0e0ce8b966ed</id>
<updated>2025-12-23T20:08:38-05:00</updated>
<summary type="html" ><![CDATA[ONKURE THERAPEUTICS INC (RPHM)]]></summary>
</entry>
</feed>